ArticleJournal of neural transmission (Vienna, Austria : 1996)2026
Motor and non-motor features in progressive supranuclear palsy: the impact of microtubule associated protein tau haplotypes among a Tunisian cohort.
Article in Journal of neural transmission (Vienna, Austria : 1996), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Opposite molecular sex correlations in tauopathy paralleled by motor and cognitive efficacy of davunetide in women.Molecular psychiatry · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Progressive supranuclear palsy (PSP) is a neurodegenerative disorder that impacts movement and cognition,caused by abnormal tau protein accumulation in the brain. It involves tau aggregation with 4-repeat domains in various brain regions and cell types. PSP is associated with the tau gene (MAPT),which contains recurrent genomic inversion. Evaluate the distribution and clinical impact of MAPT haplotypes on both motor and non-motor features among Tunisian PSP cohort. We conducted a cross-sectional study where we retrospectively review the medical records of all patients diagnosed with PSP, reclassifying them into phenotypes based on the MDS-2017 criteria. The phenotypes were categorized into three subgroups: Richardson's syndrome (PSP-RS), PSP-cortical and PSP-subcortical. We collected data on clinical and neuropsychological assessments, and genotyping for MAPT haplotypes were performed using classic PCR methods, with validation by Sanger sequencing. We included 118 patients, stratifying them into three groups: 44.06% patients with PSP-RS, 31.35% with cortical PSP, and 24.57% with subcortical PSP. Regarding the MAPT genotype, female predominance was observed among H1/H1 carriers (p = 0.0096). For motor features, homozygous H1 carriers developed parkinsonism earlier (p = 0.041), more frequent Freezing of gait (p = 0.028) and vertical supranuclear gaze palsy (p = 0.041),with earlier development of oculomotor signs associated (p = 0.034). In terms of non-motor features, the homozygo0us MAPT genotype was more associated with cognitive impairment than the heterozygous profile (p = 0.0234). Memory impairment as inaugural symptom was more common in homozygous MAPT patients (p = 0.025), as was language impairment (p = 0.011). These findings suggest that PSP is linked to haplotype-dependent increases in 4-repeat (4R) tau mRNA, which may contribute to the pathogenesis of PSP and influence its clinical phenotype.
Indexed as
Identifiers
40810960What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.